comparemela.com
Home
Live Updates
UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2023 Earnings Call Transcript : comparemela.com
UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the UroGen Pharma Q1 2023 Earnings Call. Please be advised that today's conference is being recorded.
Related Keywords
Chicago ,
Illinois ,
United States ,
San Diego ,
California ,
Americans ,
Joseph Jacob ,
Sandip Prasad ,
Matt Kaplan ,
Ram Selvaraju ,
Vincent Perrone ,
Dong Kim ,
Urogen Pharma ,
Paul Choi ,
Craig Labbate ,
Jeffrey Bova ,
Rohan Mathur ,
Liz Barrett ,
Mark Schoenberg ,
Elizabeth Barrett ,
Kols Jennifer Linehan ,
Jeff Bova ,
Don Kim ,
Hc Wainwright Co ,
Urogen Pharma Ltd ,
Goldman Sachs ,
Ladenburg Thalmann ,
Nasdaq ,
Call Transcript May ,
Gen Pharma ,
Head Investor ,
First Quarter ,
Business Update Conference ,
Chief Executive Officer ,
Chief Medical Officer ,
Chief Commercial Officer ,
Chief Financial ,
Urology Association Meeting ,
Jennifer Linehan ,
Boris Peaker ,
comparemela.com © 2020. All Rights Reserved.